期刊文献+

20岁以下免疫耐受期慢性乙肝YMDD自然变异的流行病学调查 被引量:1

Epidemiological Survey for Spontaneous HBV YMDD Motif Mutation of CHB Patients whom under 20 Years Old and in Immune Tolerant Phase
下载PDF
导出
摘要 目的探讨20岁(含20岁,下同)以下免疫耐受期慢性乙肝患者YMDD自然变异的发生情况及影响其变异的因素。方法筛选110例20岁以下处于免疫耐受期且从未接受过抗病毒治疗的慢性乙肝(chronic hepatitis B,CHB)患者,检测其YMDD变异情况。结果 110例患者检测出YMDD变异31例(28.18%),其中YIDD阳性9例、YVDD阳性6例,YIDD和YVDD同时阳性16例。患者性别、年龄、HBeAg状态、血清HBV DNA水平及丙氨酸氨基转移酶(ALT)水平对YMDD自然变异检出率无显著影响(P〉0.05)。结论 20岁以下处于免疫耐受期的CHB患者存在YMDD自然变异,其自然变异的发生率与患者性别、HBeAg水平、血清HBVDNA水平及丙氨酸氨基转移酶(ALT)水平无明显相关。 Objective To investigate the spontaneous mutation rate of HBV YMDD motif and its related factors of CHB patients whom under 20 years old and in immune tolerant phase .Methods To filtrate 110 CHB cases whom under 20 years old and in immune tolerant phase,at the same time these cases do not be treated by any antivirus drugs, then check it YMDD mutations. Rusults Among 110 cases with CHB, spontaneous YMDD variants were detected in 31 cases(YIDD , YVDD and YIDD/YVDD for 9 , 6and 16 cases, respectively).Gender , age , HBeAg status , serum HBV DNA levels and alanine aminotransferase (ALT)levels were not found to be significantly related with spontaneous YMDD mutation.Conclusions Spontaneous YMDD variants exist in patients with CHB (whom under 20 years old and in immune tolerant phase) , and are unrelated with gender , age , HBeAg status , serum viral levels or ALT levels.
作者 潘怀强 曾庆磊 屈军校 徐光华 李延军 冯继红 PAN Huai-qiang,ZENG Qing-lei,QU Jun-xiao,XU Guang-hua,LI Yan-jun,FENG Ji-hong (The Department of Infectious Diseases of The Affiliated Hospital of Yan'an University,Yan'an 716000)
出处 《医学信息》 2010年第13期2094-2095,共2页 Journal of Medical Information
基金 延安市科技计划项目(2007)
关键词 20岁以下 乙肝病毒 YMDD自然变异 under 20 years old HBV Spontaneous YMDD Motif Mutation
  • 相关文献

参考文献5

二级参考文献58

共引文献760

同被引文献22

  • 1陈立,张欣欣.核苷(酸)类似物耐药变异对乙型肝炎病毒生物学特性的影响[J].中国实用内科杂志,2007,27(15):1230-1232. 被引量:7
  • 2Iser DM,Lewin SR. Future directions in the treatment of HIV-HBV coinfection. HIV Ther, 2009, 3(4): 405-415.
  • 3AudsleyJ, Littlejohn M, Yuen L, et al. HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing. Virology, 2010, 405(2): 539-547.
  • 4Thio CL,Locarnini S. Treatment of HIV/HBV coinfection: clinical and virologic issues. AIDS Rev, 2007, 9(1): 40-53.
  • 5Hoffmann Cl.Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis, 2007, 7 ( 6 ): 402-409.
  • 6张福杰,尚红,吴昊,译.艾滋病诊疗学(2007版).北京:人民卫生出版社,2009:57—68.
  • 7Akarsu M, Sengonul A, Tankurt E, et al. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.J Gastroenterol Hepatol, 2006, 21 (12): 1783-1788.
  • 8HeoJ, Cho M, Kim HH, et aI. Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.J Korean Med Sci, 2004, 19 (4): 541-546.
  • 9Papatheodoridis GV, Deutsch M. Resistance issues in treating chronic hepatitis B. Future Microbiol, 2008, 3(5): 525-538.
  • 10De Clercq E, Ferir G, Kaptein S, et al. Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses, 2010, 2(6): 1279-1305.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部